Subscribe to Newsletter
Subspecialties Retina

Benchmarking ROP

Retinopathy of prematurity (ROP) is a potentially blinding disorder that principally affects prematurely born infants – the smaller a baby is at birth, the more likely it will develop ROP. The disease affects the immature retinal vasculature and can be mild (with no visual defects) or aggressive (with neovascularization) in presentation, potentially leading to retinal detachment and blindness. Prevalence varies from 5–8 percent in developed countries to up to 30 percent in developing countries.

Peripheral retinal ablation is a common approach to ROP, with scleral buckling and/or vitrectomy considered in more severe cases. Intravitreal anti-VEGF therapy has been shown to be of benefit in aggressive cases, but the ocular and systemic safety profile of these agents in infants with ROP is currently poorly characterized.

To provide insight into the past and predictions for the future, a series of metrics were applied to the last five years of the published literature. We asked:

  • What are the major topics?
  • Which publications have the greatest impact?
  • How is the knowledge available online?
  • Who are the most prolific authors?

PubMed was searched for retinopathy of prematurity with results limited to the last five years, in humans (for a clinical focus). The data were analyzed in Microsoft Excel 2013.

Articles are categorized according to PubMed criteria. Clinical study represents a clinical evaluation of a drug, device or technique that was not a clinical trial.
Receive content, products, events as well as relevant industry updates from The Ophthalmologist and its sponsors.

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

About the Author
Mark Hillen

I spent seven years as a medical writer, writing primary and review manuscripts, congress presentations and marketing materials for numerous – and mostly German – pharmaceutical companies. Prior to my adventures in medical communications, I was a Wellcome Trust PhD student at the University of Edinburgh.

Related Product Profiles
Uncover the Unique DNA of SPECTRALIS®

| Contributed by Heidelberg Engineering

Subspecialties Retina
ForeseeHome® – remote monitoring to help detect wet AMD earlier and improve outcomes

| Contributed by Notal Vision

Product Profiles

Access our product directory to see the latest products and services from our industry partners

Here
Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: